↓ Skip to main content

Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management

Overview of attention for book
Overall attention for this book and its chapters
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
2 news outlets
twitter
19 X users
facebook
2 Facebook pages
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
111 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management
Published by
Advances in experimental medicine and biology, January 2016
DOI 10.1007/978-3-319-24932-2
ISBNs
978-3-31-924931-5, 978-3-31-924932-2
Editors

Aamir Ahmad, Shirish M. Gadgeel

X Demographics

X Demographics

The data shown below were collected from the profiles of 19 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 111 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 111 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 3%
Student > Ph. D. Student 3 3%
Student > Master 2 2%
Student > Doctoral Student 1 <1%
Researcher 1 <1%
Other 1 <1%
Unknown 100 90%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 6 5%
Agricultural and Biological Sciences 2 2%
Medicine and Dentistry 2 2%
Engineering 1 <1%
Unknown 100 90%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 30. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 March 2023.
All research outputs
#1,305,445
of 25,498,750 outputs
Outputs from Advances in experimental medicine and biology
#166
of 5,260 outputs
Outputs of similar age
#22,103
of 400,387 outputs
Outputs of similar age from Advances in experimental medicine and biology
#25
of 443 outputs
Altmetric has tracked 25,498,750 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,260 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 400,387 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 443 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.